7/12/24 17:46 | 7/10/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | M.d | 188 | 14.55 | 0 | 13 | 1 | 1,059 | D | | | | | | | | | | | | | | |
7/12/24 17:46 | 7/10/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.d | -291 | 22.49 | 0 | -13 | -1 | 1,059 | D | | | | | | | | | | | | | | |
6/26/24 17:07 | 6/24/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | M.d | 186 | 14.42 | 0 | 13 | 1 | 1,059 | D | | | | | | | | | | | | | | |
6/26/24 17:07 | 6/24/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.d | -299 | 23.10 | 0 | -13 | -1 | 1,059 | D | | | | | | | | | | | | | | |
2/12/24 20:22 | 2/8/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S | -2,496 | 27.13 | 0 | -92 | -8 | 1,059 | D | | | | | | | | | | | | | | |
1/25/24 16:59 | 1/23/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S | -105 | 18.41 | 0 | -6 | 0 | 1,151 | D | | | | | | | | | | | | | | |
1/8/24 16:19 | 12/15/23 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.m | -1,959 | 19.15 | 0 | -102 | -8 | 1,157 | D | | | | | | | | | | | | | | |
2/23/23 19:56 | 2/21/23 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.m | -710 | 20.61 | 0 | -34 | -2 | 1,859 | D | | | | | | | | | | | | | | |
1/23/23 19:57 | 1/19/23 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.m | -392 | 20.10 | 0 | -20 | -1 | 1,894 | D | | | | | | | | | | | | | | |
12/19/22 17:56 | 12/15/22 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DOT | CEO | S.m | -2,018 | 23.23 | 0 | -87 | -4 | 1,913 | D | | | | | | | | | | | | | | |